Separate literature from labeling
Published papers can inform clinical education but do not rewrite the product label or create FDA approval.
File literature separately from lot documents and ask whether cited papers studied the commercial SKU you would buy.
Request format that gets answers
Use a written request listing SKU, intended review purpose, and deadline. Track what was received.
Reject vague lots of studies answers without citations.
Review discipline
Have a clinician owner skim relevance and a quality owner confirm literature is not used as a substitute COA.
Marketing must stay within compliant, non-disease, non-efficacy claims even when papers are positive.
Operational checklist for request supporting literature biologics
Before ordering under the topic request supporting literature biologics, confirm storage class, receiving owner, and which documents will be required at release.
Close open items in writing. Do not infer missing COA fields from a different lot or SKU.
Frequently asked questions
Who should receive shipments?+
A trained receiving designee named in the SOP.
Can we skip documentation if a physician is waiting?+
No. Identity and condition checks come first.
Do all SKUs share one SOP?+
Use parallel SOPs when storage class or labeling differs.
Does this page determine how we may use products discussed under request supporting literature biologics?+
No. Intended use remains with the ordering physician and clinic counsel.